ENVB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Enveric Biosciences Inc (ENVB) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock shows no strong positive signals, has weak technical indicators, and lacks significant positive catalysts or financial growth trends to justify a buy decision.
The stock is in a bearish trend with the MACD histogram below 0 and negatively contracting, RSI at 11.953 indicating oversold conditions, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels suggest the stock is trading near its lower range, with S1 at 2.083 and S2 at 1.807. Overall, the technical indicators do not support a buy decision.
NULL. There is no recent news, no significant insider or hedge fund activity, and no recent congress trading data. The stock also lacks any AI Stock Picker or SwingMax signals.
The stock has shown a regular market decline of -4.27% and is trading in a bearish technical setup. Additionally, there are no significant trading trends or positive news to drive momentum.
In Q3 2025, the company reported no revenue growth (0% YoY), a net income loss of -$3,387,118 (up 62.53% YoY), and an EPS of -129.76 (up 201.07% YoY). Despite some improvement in net income and EPS, the company remains unprofitable with no revenue growth, which is a concern for long-term investment.
No analyst rating or price target data available.
